Georgia Man and His Company Charged with Selling Misbranded Drug Advertised to Treat COVID-19
Date of publication: 10-08-2020
FDA OCI, Matthew Ryncarz, Fusion Health and Vitality, Pharm Origins, selling, misbranded drug, “Immune Shot”, lower risk, COVID-19, coronavirus, targeted ages 50 and older, heavy-handed sales pitch, complaint, health care fraud, Fraud National Hotline, $19 per bottle, Źródło: http://www.fda.gov
